Page 199 - Tata_Chemicals_yearly-reports-2017-18

&RQVROLGDWHG 6WDWHPHQW RI &DVK )ORZV IRU WKH \HDU HQGHG 0DUFK
` in crore
Particulars Year ended Year ended
31 March, 2018 31 March, 2017
A Cash flows from operating activities
Profit before tax from continuing operations 1,620.13 1,466.58
Profit before tax from discontinued operations 1,651.71 185.59
3,271.84 1,652.17
Adjustments for :
Depreciation and amortisation expense 530.59 552.44
Impairment of assets (note 34) 65.40 -
Finance costs 388.99 472.97
Interest income (22.98) (8.51) Integrated Report
Dividend income (60.31) (65.62)
Profit on sale of discontinued operation (note 34) (1,279.39) -
Share of profit of joint ventures (49.23) (15.62)
Net gain on sale of current investments (52.70) (2.30)
Provision for employee benefits expense 34.33 76.88
Provision for doubtful debts and advances/bad debts written off 55.04 3.91
Provision for contingencies 66.75 52.85
Liabilities no longer required written back (24.88) (15.19)
Realised foreign exchange loss due to financing activities 3.87 69.41
Unrealised foreign exchange loss/(gain) (net) 15.83 (7.93)
Loss on assets sold or discarded (net) 10.80 4.09
Operating profit before working capital changes 2,953.95 2,769.55
Adjustments for : Statutory Reports
Trade receivables, loans, other financial assets and other assets (251.33) 1,115.55
Inventories (118.60) 427.24
Trade payables, other financial liabilities and other liabilities (199.18) (329.89)
Cash generated from operations 2,384.84 3,982.45
Taxes paid (net of refund) (514.70) (451.57)
Net cash generated from operating activities 1,870.14 3,530.88
B Cash flows from investing activities
Acquisition of property, plant and equipment (including capital work-
in-progress, intangible assets and intangible assets under development) (750.32) (645.30)
Proceeds from sale of property, plant and equipment 19.72 2.40
Proceeds from sale of other non-current investments 937.38 5.19
Proceeds from sale of current investments 14,944.94 11,019.18
Purchase of non-current investments (40.14) (0.50) Financial Statements
Purchase of current investments (14,766.70) (11,230.30)
Purchase of investments in joint ventures (1.91) (13.14)
Bank balances not considered as cash and cash equivalent (322.59) (194.19)
Proceeds from sale of discontinued operations (net) (note 34) 2,593.98 -
Proceeds from sale of subsidiaries 0.03 -
Interest received 22.49 8.05
Dividend received 70.13 85.96
Consideration paid on acquisition/investment in subsidiary - (19.49)
Net cash from/(used in) investing activities 2,707.01 (982.14)

Consolidated Financial Statements 197